Valérie Widmer Selected Research

IMA950

11/2019	Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients.
1/2018	Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valérie Widmer Research Topics

Disease

6	Neoplasms (Cancer) 01/2020 - 05/2003
4	Glioma (Gliomas) 01/2020 - 01/2018
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2018
2	Astrocytoma (Pilocytic Astrocytoma) 11/2019 - 01/2018
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Oligodendroglioma 01/2018
1	Ependymoma 01/2018
1	Testicular Neoplasms (Testicular Cancer) 05/2005

Drug/Important Bio-Agent (IBA)

4	VaccinesIBA 01/2020 - 05/2005
3	AntigensIBA 11/2019 - 05/2005
2	Peptides (Polypeptides)IBA 01/2020 - 01/2018
2	IMA950IBA 11/2019 - 01/2018
2	Protein Subunit VaccinesIBA 11/2019 - 05/2005
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	SteroidsIBA 01/2020
1	poly ICLCIBA 11/2019
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 11/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2019
1	Poly I-CIBA 11/2019
1	PolylysineIBA 11/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	EpitopesIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	peptide NY-ESO-1 157-165IBA 05/2005
1	Immunodominant EpitopesIBA 05/2005
1	AutoantigensIBA 05/2003

Therapy/Procedure

2	Chemoradiotherapy 01/2020 - 11/2019
1	Radiotherapy 01/2020
1	Adjuvant Chemotherapy 01/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Immunotherapy 01/2018